Abstract:Objective To explore the clinicopathological features,diagnosis,differential diagnosis and treatment of congenital hemangioma (CH).Methods The clinical data,pathological characteristics and treatment of 32 CH cases were analyzed retrospectively.Results There were 20 boys and 12 girls with a boy-to-girl ratio of 1.6∶1 and a median age of 43 months.All were unifocal lesions at head & neck region (n =8),trunk (n =12),upper extremities (n =5) and lower extremities (n =7).One lesion was detected by prenatal ultrasonography and the remainder was present at birth.Twenty-five lesions gradually expanded in size,3 lesions had slight regression and 4 cases showed no obvious changes.One lesion felt warm on palpation,one with sinus at the center of mass while the remainder had no local pain,swelling or ulceration.All lesions had normal preoperative results of blood routine and blood coagulation function.One child received a preoperative injection of sclerosant.However,mass had no regression.All cases underwent complete resection.One child of excessive intraoperative hemorrhage received blood transfusion postoperatively.The clinical types were rapidly involuting congenital hemangioma (RICH,n =3) and noninvoluting congenital hemangioma (NICH,n =29).NICH:Tumor was dominated by lobules of capillaries,separated by dense fibrous tissues containing lymphatic vessels and small arteriovenous structures.Small intralobular vessels were lined by endothelial cells with hobnailed nuclei.The center of lobule was occupied by stelliform vessels.RICH:Tumor was dominated by lobules of capillaries,similar to those seen in NICH,most intralobular vessels were atretic and the remainder diminished.Endothelial cells became flattened.Focal hemorrhagic necrosis,hemosiderosis and calcification were observed.Immunohistochemistry showed that all cases were negative for Glut1,positive for CD34(32/32),CD31 (32/32) and WT1 (32/32) and D2-40 was partially positive.Twenty-five cases were followed up for 3-25 months.Slight linear scar was present.Recurrence was not found.Conclusions CH is a benign vascular tumor whose diagnosis (RICH or NICH) depends upon clinical manifestations and pathological morphology.Clinically and pathologically,it needs to be differentiated from vascular malformation,infantile hemangiomas,kaposiform hemangioendothelioma and pyogenic granuloma.

Management of Giant Hemangioma of the Liver:Experience in 56 Patients

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Surgical Indication and Strategy for Liver Hemangioma in the Caudate Lobe: a Multi-Institutional Retrospective Analysis with 137 Patients.

A Report of 47 Cases of Hepatectomy in Benign Occupied Disease of the Liver

Fifteen Cases of Hemangiopericytoma in Head and Neck Region

Three-dimensional visualized technology-guided surgical resection for giant hepatic hemangioma with hemorrhagic necrosis: A case report and literature review

Value of Hepatectomy in Treatment of Benign Liver Tumors

Regular hepatic segmentectomy for giant hemangioma of the liver: An analysis of 26 cases | Chines Source

Surgical Resection of a Giant Hepatic Hemangioma in a Hepatitis B-positive Patient: A Case Report

Imaging Characteristics of and Embolization Therapy for Giant Hepatic Hemangioma

Surgical treatment for huge hepatic cavernous hemangioma closely attached to inf erior vena cava

Giant cavernous hemangioma of chest wall: clinical analysis of 7 cases

Standardized Treatment and Problems Worthy of Attention for Hemangioma of Liver

Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma

Management of congenital hemangioma: clinicopathological analysis of 32 cases

Enucleation Versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis.

Laparoscopic Hepatectomy for Hepatic Hemangioma

[ARTERIOVENOUS ANGIODYSPLASIA ASSOCIATED WITH NEVUS AND HYPOTROPHY OF THE LEGS].

Surgical treatment to the hemorrhage of spontaneous rupture of hepatocellular carcinoma: an analysis of 15 cases

Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies

Radiofrequency Ablation for Treatment of Giant Hepatic Hemangiomas